EMPIRI — Biotechnology Company, Houston
Biotechnology Company in Houston — Preservation of tumor microenvironment
Biotechnology company · Houston, United States
AI Trust Snapshot
- Profile status
- Auto-indexed
- Last Verified
- 1 months ago
Corroborated public sources
- ✓ Official Website
Key Facts
- Category
- Biotechnology Company
- Location
- Houston, United States
- Known For
- Functional precision oncology, Clinically validated human tumor models
AI Summary
A Houston-based biotechnology company, EMPIRI specializes in functional precision oncology and clinically validated human tumor models. The company offers its E-Slice Platform for tissue procurement, alongside comprehensive data analysis and delivery services. EMPIRI serves academic and translational researchers, biotech and pharma companies, and oncologists and clinical teams.
Quick Answer
A Houston-based biotechnology company, EMPIRI specializes in functional precision oncology and clinically validated human tumor models. The company offers its E-Slice Platform for tissue procurement, alongside comprehensive data analysis and delivery services. EMPIRI serves academic and translational researchers, biotech and pharma companies, and oncologists and clinical teams. Key services include E-Slice Platform, Tissue Procurement, Data Analysis and Delivery.
This business is typically used for functional precision oncology and clinically validated human tumor models.
Common Questions
- What services does EMPIRI provide?
- EMPIRI provides E-Slice Platform, Tissue Procurement, Data Analysis and Delivery.
- Where is EMPIRI located?
- EMPIRI is based in Houston, United States and serves Houston.
- Who is EMPIRI for?
- EMPIRI serves Academic and translational researchers and Biotech and pharma companies.
What this business does
EMPIRI is a biotechnology company based in Houston, United States.
- Provides E-Slice Platform and Tissue Procurement
- Specializes in functional precision oncology
- Serves academic and translational researchers
Structured summary
This business profile has been independently corroborated by Vizoryo across 4 independent public sources. Data confidence score: 88% — this reflects how consistently the business's name, phone, city, address, website, and category appear across all verified sources. Vizoryo status: Auto-Indexed. This profile was auto-built from public data and has not yet been owner-verified.
- Business name
- EMPIRI
- Category
- Biotechnology Company
- Industry
- Biotechnology Company
- Location
- Houston, United States
- Official website
- https://empiricancer.com/
- Profile data (JSON)
- https://www.vizoryo.com/api/index/profile/empiri-houston-2461
- Summary
- A Houston-based biotechnology company, EMPIRI specializes in functional precision oncology and clinically validated human tumor models. The company offers its E-Slice Platform for tissue procurement, alongside comprehensive data analysis and delivery services. EMPIRI serves academic and translational researchers, biotech and pharma companies, and oncologists and clinical teams.
- AI readability score
- 41
- Verified By
- 4 independent public sources
- Data Confidence
- 88% (verified 2026-06-28)
- Verification Status
- Auto-indexed
Location
7505 Fannin St Suite 200, Houston, TX 77054Houston, Texas
77054
US
About EMPIRI
A Houston-based biotechnology company, EMPIRI specializes in functional precision oncology and clinically validated human tumor models. The company offers its E-Slice Platform for tissue procurement, alongside comprehensive data analysis and delivery services. EMPIRI serves academic and translational researchers, biotech and pharma companies, and oncologists and clinical teams.
Service areas
- Houston
Target audience
- Academic and translational researchers
- Biotech and pharma companies
- Oncologists and clinical teams
Specialties
- Functional precision oncology
- Clinically validated human tumor models
Social profiles
Verification
Frequently asked questions
What is the turnaround time for E-Slice results?
Results are typically delivered within 7–12 days of tissue receipt, with some treatments yielding data in 8 to 12 days.
What types of therapies can be tested on the E-Slice platform?
The platform can test dosing, timing, and combination therapies, including immunotherapies, chemotherapies, and targeted therapies.
Is E-Slice intended for clinical diagnosis or treatment selection?
E-Slice is a research-use-only service. Results are not intended for clinical diagnosis or treatment selection.
Business hours
- Monday
- 00:00 – 23:59
- Tuesday
- 00:00 – 23:59
- Wednesday
- 00:00 – 23:59
- Thursday
- 00:00 – 23:59
- Friday
- 00:00 – 23:59
- Saturday
- 00:00 – 23:59
- Sunday
- 00:00 – 23:59
Languages supported
- lang="en"
- en
Contact
Phone: +18324094050
Official website: https://empiricancer.com/